EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Production of mRNA lipid nanoparticles using advanced crossflow micromixing

Muattaz Hussain, Burcu Binici, Liam O'Connor, Yvonne Perrie iD

Journal of Pharmacy and Pharmacology · 02.12.2024 · 76 (12) · 1572-1583

DOI: 10.1093/jpp/rgae122 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, online erschienen am 09.10.2024. Verfasst von Muattaz Hussain und 3 weiteren Autor:innen. Beteiligte Einrichtung: Strathclyde Institute of Pharmacy and Biomedical Sciences, 161 Cathedral St., University of Strathclyde, Glasgow, G4 0RE, United Kingdom. Hauptthemen laut MEDLINE: Nanoparticles, RNA, Messenger, Lipids. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Strathclyde 'Healthcare Nanotechnologies' Strathclyde Centre, University of Strathclyde ‘Healthcare Nanotechnologies’ Strathclyde Centre.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Lipid nanoparticles (LNPs) play a crucial role in RNA-based therapies, and their production is generally based on nanoprecipitation and coalescence of lipids around an RNA core. This study investigated crossflow micromixing to prepare LNPs across various mixing ratios and production speeds.

Methods

A range of LNPs were prepared using crossflow micromixing across production speeds of 10–500 ml/min, and their physico-chemical characteristics (size, polydispersity index (PDI), zeta potential, and mRNA encapsulation), in vitro mRNA expression and in vitro efficacy (protein expression and antibody and cytokine responses). Key findings Our results demonstrate the reproducible production of mRNA–LNPs with controlled critical quality attributes, including high mRNA encapsulation from the initial screening scale through to GMP-scale production, where the same mixing ratio can be adopted across all product speeds from 30 to 500 ml/min used.

Conclusions

We confirm the applicability of stainless-steel crossflow membrane micromixing for the entire spectrum of mRNA–LNP production, ranging from initial discovery volumes to GMP-production scale.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanoparticlesRNA, MessengerLipidsParticle SizeHumansCytokinesAnimalsLiposomes

Stichwörter der Autor:innen

lipid nanoparticlesmRNAmanufacturingmicromixingvaccines

Substanzen

RNA, MessengerLipidsLipid NanoparticlesCytokinesLiposomes

Autor:innen und Institutionen

  • Strathclyde Institute of Pharmacy and Biomedical Sciences, 161 Cathedral St., University of Strathclyde, Glasgow, G4 0RE, United Kingdom.

ORCID-Profile: Yvonne Perrie

Förderung

  • University of Strathclyde 'Healthcare Nanotechnologies' Strathclyde Centre
  • University of Strathclyde ‘Healthcare Nanotechnologies’ Strathclyde Centre

Zitieren

APA

Hussain, M., Binici, B., O'Connor, L., & Perrie, Y. (2024). Production of mRNA lipid nanoparticles using advanced crossflow micromixing. Journal of Pharmacy and Pharmacology, 76(12), 1572-1583. https://doi.org/10.1093/jpp/rgae122

Vancouver

Hussain M, Binici B, O'Connor L, Perrie Y. Production of mRNA lipid nanoparticles using advanced crossflow micromixing. Journal of Pharmacy and Pharmacology. 2024;76(12):1572-1583. doi:10.1093/jpp/rgae122

BibTeX
@article{Hussain2024,
  author = {Hussain, Muattaz and Binici, Burcu and O'Connor, Liam and Perrie, Yvonne},
  title = {Production of mRNA lipid nanoparticles using advanced crossflow micromixing},
  journal = {Journal of Pharmacy and Pharmacology},
  year = {2024},
  volume = {76},
  number = {12},
  pages = {1572--1583},
  doi = {10.1093/jpp/rgae122}
}
Kostenlos starten →